Orthofix Medical Inc.
OFIXHealthcareNASDAQMedical Devices
Scan Results
Daily timeframeHeadquartered within the healthcare sector, Orthofix Medical Inc. focuses on Medical Devices services and products. Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. The company carries a $468.1M market cap, placing it firmly in the small-cap category. It operates through two segments, Global Spine and Global Limb Reconstruction.
Market Cap
$468.1M
Beta
0.71
P/E (TTM)
—
P/E (Fwd)
13.79
EPS (TTM)
$-1.46
EPS (Fwd)
$0.84
ROE
-13.4%
ROA
-3.3%
Cash
$120.3M
Total Debt
$262.3M
Free CF
$22.0M
52W Change
8.9%
Annual Financials
Cash vs Debt
The company holds $120.3M in cash, though total debt stands at $262.3M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. The company generates $22.0M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of -13.4% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has grown from $460.7M (2022) to $822.3M (2025), reflecting a 78% increase over the period.
As with any equity investment, OFIX carries market risk, sector-specific risk, and company-specific risk that investors should evaluate in the context of their own portfolios. No single metric tells the full story. Reviewing OFIX's risk profile alongside its fundamentals and technical indicators provides a more complete picture.